An Incisive, In-depth Analysis on the Gamma Knife Market
This study offers a comprehensive, 360 degree analysis on the Gamma Knife market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Gamma Knife market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
On the back of exhaustive research on its efficacy and high success rate, Gamma Knife continues to gain traction among healthcare centres as a highly effective radiosurgery system. Stereotactic radiation therapy equipment revenues account for nearly 10% share of the global radiation therapy equipment revenues in 2013. Linear Accelerator (LINAC) remains the widely used radiation therapy treatment procedure – nearly 50% of patients undergoing radiation therapy were treated using LINAC.
Gamma Knife and Cyber Knife are the two widely used stereotactic radiation therapy procedures. Global Gamma Knife equipment revenues were estimated at US$ 172 million in 2015, and the market is expected to increase at a compound annual growth rate (CAGR) of 9.1% through 2025. The key factors expected to drive adoption of Gamma Knife include,
-
Increase preference toward non- and minimally-invasive procedures
-
High success rate of Gamma Knife treatment
-
Positive perception among healthcare providers (over 2,800 peer reviewed journal articles)
-
Focus on developed novel treatment procedures for neurological disorders
-
Comprehensive health insurance cover for radiation therapy
(Detailed analysis of key drivers available in the report)
Although Gamma Knife has proven to be a highly effective treatment option, high cost, low equipment availability, and lack of awareness in developing markets can inhibit adoption. The cost of a Gamma Knife is in the range of US$ 4 Mn to US$ 5 Mn, with additional setup costs of US$ 1 Mn to US$ 2 Mn. Total investment in procuring a machine can add up to US$ 7 Mn. The high cost of Gamma Knife has remained a longstanding challenge, however, it is expected that technological advancement will lead to cost reduction in the future.
Gamma Knife Market Analysis by Disease Indication
Gamma Knife is currently being used in treating a wide range of disease indications. The key disease indications include,
- Brain metastasis – 68.5% revenue share of the global market
- Cancer
- AVM (arteriovenous malformation)
- Trigeminal Neuralgia
- Others (pituitary tumour, epilepsy, acoustic neuroma, and Parkinson’s)
While brain metastasis will continue to be the leading disease indication for Gamma Knife, the others segment (pituitary tumour, epilepsy, acoustic neuroma, and Parkinson’s) is projected to increase at the highest CAGR during the forecast period.
Asia Pacific will Pip North America to Become the Largest Gamma Knife Market
On the back of strong adoption in the U.S. healthcare sector, North America has remained the largest market for Gamma Knife. However, during the forecast period 2015-2025, Asia Pacific will emerge as the most lucrative market, driven by robust adoption of Gamma Knife in China, India, Japan, and South Korea. North America’s revenue share will decrease to 25% in 2025, 4% lower than the current revenue share. The Gamma Knife market in Europe will continue to remain steady, with hospitals and clinics in EU5 countries accounting for the bulk of demand. Gamma Knife market in Middle East & Africa (MEA) and Latin America will grow at high CAGR owing to the small base of market in these regions.
| Gamma Knife Market: Region-wise Analysis (US$ Mn) | |||
|---|---|---|---|
| Region | 2014 | 2025 | CAGR |
| North America | 46.3 | XX | XX |
| Asia Pacific | XX | 131.5 | XX |
| Europe | XX | XX | XX |
| Latin America | XX | XX | XX |
| Middle East & Africa | XX | XX | 11.70% |
(Concealed figures available in the report)
Leading Gamma Knife Equipment Manufacturers
Elekta, Varian Medical Systems, and Huiheng Medical, Inc. are the top three Gamma Knife equipment manufacturers. While Elekta and Varian Medical Systems have a strong presence in North America and Europe, China-based Huiheng Medical, Inc. caters mainly to healthcare centres in Asia Pacific. A detailed analysis on the competitive landscape is included in the report.
This Future Market Insights report examines the ‘Global Gamma Knife’ market for the period 2012-2025. The primary objective of the report is to offer updates on the advancement of Gamma Knife, examining the marketing efforts and business strategies undertaken by the manufacturing companies which is significantly transforming the Stereotactic Radiosurgery market. This study analyses, estimates and forecasts the global Gamma Knife market from the demand as well as supply perspective, in terms of revenue (US$ Mn) during the forecast period 2015 to 2025. The report also highlights the impact of various drivers and restraints in various regions along with their impact during the forecast period.
The report starts with an overview of Gamma Knifein treatment in various indications such as Brain Metastasis, Cancer, Arteriovenous Malformation (AVM), Trigeminal Neuralgia and Others. For example, Cobalt-60 radioactive isotope is increasingly being used for the treatment of brain tumours and cancers in order to increase life expectancy. Moreover, market expansion and innovation in techniques as well as development of novel applications in Stereotactic Radiosurgery are further driving Gamma Knife market growth. Due to these reasons, Gamma Knife market is expected to have a significant demand in the near future.
There are five major types of Gamma Knife indications which have been covered in this report: Brain Metastasis, Cancer, Arteriovenous Malformation (AVM), Trigeminal Neuralgia and Others. Brain Metastasis treatment contribute around 68.5% share of the global Gamma Knife value in 2014, Brain Metastasis is anticipated to witness a CAGR of 9.2% during the forecast period.
Considering the type of body part treated with Gamma Knife, the global Gamma Knife market is segmented into: Head, Neck and Other body parts. Among the aforementioned segments, Head treatment with Gamma Knife is expected to dominate the global market with over 88.1% market value share throughout the forecast period. The global head treatment with Gamma Knife accounted for US$ 139.8 Mn in 2014, and is anticipated to reach a value of US$ 364.8 Mn by 2025, growing at a CAGR of 9.2% during the forecast period. Moreover, the scope of Gamma Knife treatment in other indications is expected to expand in the future too, due to market expansion and innovation in techniques. This section analysis each indications in terms of market revenue.
On the bases of region, North America dominated the global Gamma Knife market in 2014, in terms of revenue, accounting for more than 29.2% of the revenue share in 2014. However, Europe and Asia Pacific are foreseen to witness relatively high CAGRs of 7.7% and 10.5% respectively. The report provides market revenue for each geographical region.
The global Gamma Knife market in terms of indications, anatomy and region are analysed in terms of Basis Point Share to understand individual segments relative contributions to market growth. This detailed level of information is important for the identification of various key trends of the global Gamma knife market.
All the above sections, by indications, by type of organs treated and by geography evaluate the present scenario and the growth prospects of the global Gamma Knife market for the period 2015 to 2025. Given the characteristics of the market, we triangulated the outcome of three different types of analyses, based on supply side, healthcare spending and economic envelope. In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities across the global Gamma Knife market.
Furthermore, to understand key growth segments in terms of growth & adoption of global Gamma Knife market, Future Market Insights developed the global Market Attractiveness Index on the bases of indications, by type of organs treated and geography. The resulting index should help providers identify real market opportunities.
In the final section of the report, the global Gamma Knife competitive landscape is included to provide report audiences with a dashboard view, based on various segments, presence in global Gamma Knife market and key differentiators. This section is primarily designed to provide clients with an objective & detailed comparative assessment of key providers specific to a market segment in the global Gamma Knife value chain. Detailed profiles of the manufactures are also included in the scope of the report to evaluate their operations, expansions, products and sales channel strategies along with the SWOT analysis for each manufacture. Key competitors included are Elekta AB, Varian Medical Systems, Inc. and Huiheng Medical, Inc.
COVID -19 : Impact Analysis
Request the coronavirus impact analysis across industries and markets
Request Covid -19 ImpactGet in touch
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.